Results 141 to 150 of about 1,628,316 (351)
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy [PDF]
Background: Fibrosis may be considered the hallmark of systemic sclerosis (SSc), the end stage triggered by different pathological events. Transforming growth factor-β (TGF-β) and platelet-derived growth factor BB (PDGF-BB) are profibrotic molecules ...
Berardicurti O.+11 more
core +1 more source
Lower-limb Ulcers in Systemic Sclerosis: A Multicentre Retrospective Case-control Study
Lower-limb ulcers in systemic sclerosis patients are rarely reported. The aim of this study was to describe the main causes and outcomes of lower-limb ulcers in systemic sclerosis patients and to assess factors associated with ischaemic causes (arterial ...
Gérôme Bohelay+12 more
doaj +1 more source
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
BackgroundSystemic sclerosis (SSc) is a rare connective tissue disease with a heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of SSc and a leading cause of death.Main bodyAll patients newly diagnosed with SSc ...
V. Cottin, K. Brown
semanticscholar +1 more source
A continuous injection method fabricates a multi‐layer liquid metal sensor by laminating PDMS microfluidic layers, decoupling pressure, and deformation measurements. Its compact, thin design integrates into fingers or robotic digits, enabling material hardness identification via contact deformation.
Tao Yue+4 more
wiley +1 more source
Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease. [PDF]
OBJECTIVE: To examine whether lung endothelial cells (ECs) from patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) express mesenchymal cell-specific proteins and gene transcripts, indicative of the occurrence of endothelial-
Arciniegas+41 more
core +2 more sources
Therapeutic Promise of Hyaluronidase in Systemic Sclerosis: A Systematic Review
Introduction: Systemic sclerosis, also known as scleroderma, is a chronic disease marked by autoimmune-mediated damage to connective tissues leading to vascular damage, tissue injury, and fibrosis.
Anika Pulumati, Rachel Lin, Scott Elman
doaj +1 more source
Systemic sclerosis is a rare chronic autoimmune disease with extensive microvascular injury, damage of endothelial cells, activation of immune responses, and progression of tissue fibrosis in the skin and various internal organs.
Mina Abedi+7 more
doaj +1 more source
Treatment Algorithms for Systemic Sclerosis According to Experts
There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.
A. Fernández-Codina+2 more
semanticscholar +1 more source
ABSTRACT In 2019, the Australian government established the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (‘Disability Royal Commission’, DRC) to investigate widespread mistreatment of people with disability. Nearly 10,000 people with disability, their families and supporters engaged with the DRC.
Kate D'Cruz+7 more
wiley +1 more source